$1.52
+0.05 (+3.40%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,900.0% upside
Low Target
$22.94
Average Target
$30.40
High Target
$39.68
Current Price
$1.52
Current
$1.52
$1.52
Target
$30.40
$30.40
$22.94
$30.40 avg
$39.68
Scenario Analysis
Bear Case
$22.94
1,409.2%
Low target
Base Case
$30.40
+1,900.0%
Avg target
Bull Case
$39.68
+2,510.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$4.19
-63.7% from high
52-Week Low
$1.09
+39.4% from low
Target vs 52W High
$30.40
+625.4% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.2% |
| AMGN | Hold | 43 | 47% | $190.87 | -54.9% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +139.7% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -16.8% |
| REGN | Buy | 38 | 68% | $76.80 | -89.8% |
| MRNA | Hold | 30 | 37% | $149.45 | -26.5% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -65.5% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.2% |